Reposted by @piusgalli.bsky.social
Congrats to Pius, Shuhao, and the team!
Check out our latest publication:
Molecular glue degraders (MGDs) like lenalidomide have transformed multiple myeloma treatment by inducing degradation of non-native substrates via the CRL4CRBN E3 ligase—but which proteins can they actually reach?
